David C. Marek - 19 Apr 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Principal Executive Officer, Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Apr 2022
Net transactions value
-$257,007
Form type
4
Filing time
21 Apr 2022, 16:25:00 UTC
Previous filing
19 Apr 2022
Next filing
20 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $257,007 -24,594 -5.2% $10.45 447,956 19 Apr 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 The shares were sold at prices ranging from $10.41 to $10.48. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.